China’s medical regulator has granted a world-first commercial green light to a brain-computer interface, with a system ...
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way ...
CNS Pharma wipes glioblastoma pipeline clean in strategic pivot to fresh neurology, oncology targets
“Strategic transformations are a common and often successful approach in biotechnology,” Rami Levin, who took over as CEO of ...
This is a developing story. Please check back for updates. | After a tumultuous tenure marked by recent clashes with the ...
According to a report from Bloomberg, the pro-Iran group Handala has publicly taken credit for the incident on social media, in response to the U.S. and Israeli strikes on the country, with claims of ...
BD has inked a technological partnership with automation provider Sinteco, aimed at pharmacy robotics. | The goal is to ...
Vistagen Therapeutics is doubling down on its lead social anxiety candidate, even after the asset failed a phase 3 trial last December. | Vistagen Therapeutics is doubling down on its lead social ...
Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash transaction valued at $950 million. | Bay Area ...
In a strikingly blunt briefing, a senior FDA official accused uniQure of pushing “distorted” data to mask a “failed” therapy ...
Funding from the National Institutes of Health (NIH) generated $94.15 billion in economic activity and supported 390,863 jobs in 2025, according to a ...
Monoclonal antibodies have become one of the most established and clinically successful therapeutic modalities, supported by ...
Zealand Pharma’s Roche-partnered amylin analog demonstrated “placebo-like tolerability” and up to 10.7% mean weight loss at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results